HuidaGene Therapeutics

CMN Weekly (11 October 2024) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

CMN Weekly (27 September 2024) - Your Weekly...

Some of the best links we picked up around the internet

CMN Weekly (10 May 2024) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

CMN Weekly (12 April 2024) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

CMN Weekly (16 February 2024) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

HuidaGene Receives Special Designation for...

HuidaGene Therapeutics recently announced that the FDA has granted Orphan Drug Designation to its CRISPR-based therapeutic candidate, HG302. The...

HuidaGene Therapeutics

Congenital Hearing Loss, (NCT06025032)
Sponsors:
HuidaGene Therapeutics Co., Ltd.

IND Enabling

Phase I

Phase II

Phase III

Neovascular Age-related Macular Degeneration, nAMD, (NCT06031727)
Sponsors:
HuidaGene Therapeutics Co., Ltd.

IND Enabling

Phase I

Phase II

Phase III

Search CRISPR Medicine